➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
McKesson
Mallinckrodt
Colorcon
Baxter

Last Updated: May 15, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021910

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 021910 describes NORMOCARB HF 35, which is a drug marketed by Dialysis Sups and is included in one NDA. Additional details are available on the NORMOCARB HF 35 profile page.

The generic ingredient in NORMOCARB HF 35 is magnesium chloride; sodium bicarbonate; sodium chloride. There are one hundred and forty-six drug master file entries for this compound. Additional details are available on the magnesium chloride; sodium bicarbonate; sodium chloride profile page.
Summary for 021910
DrugPatentWatch® Estimated Generic Entry Opportunity Date for 021910
Generic Entry Date for 021910*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;INJECTION

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INJECTIONStrength0.21GM/100ML;2.8GM/100ML;9.07GM/100ML
Approval Date:Jul 26, 2006TE:RLD:Yes
Patent:  Get Started for $10Patent Expiration:Mar 4, 2023Product Flag?YSubstance Flag?Delist Request?

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INJECTIONStrength0.21GM/100ML;3.97GM/100ML;8.3GM/100ML
Approval Date:Jul 26, 2006TE:RLD:Yes

Expired US Patents for NDA 021910

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dialysis Sups NORMOCARB HF 25 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-001 Jul 26, 2006   Get Started for $10   Get Started for $10
Dialysis Sups NORMOCARB HF 35 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-002 Jul 26, 2006   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Merck
McKesson
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.